AR-guided sentinel node detection in breast cancer surgery
Part of Cancer, Skin clinical trials.
This study tests a new device that uses augmented reality and a special dye to help surgeons find the sentinel lymph node (the first node that cancer might spread to) during breast cancer surgery. It may help make the node removal more precise and reduce unnecessary removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer (confirmed by biopsy).
- You are 18 years old or older.
- You are scheduled to have breast cancer surgery that includes checking or removing lymph nodes under your arm.
- You have not had chemotherapy before surgery.
- You have not had prior breast surgery on the affected side.
- You are not allergic to iodine, shellfish, or the dye used in this study (indocyanine green).
- You are not pregnant and are willing to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way for surgeons to find leftover cancer cells in the lymph nodes after they have been removed during breast cancer surgery. It uses a special dye and augmented reality to help make sure no cancer is missed.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This study tests whether a special dye called indocyanine green (ICG) can help find sentinel lymph nodes during breast cancer surgery after chemotherapy. It may offer a safer and more effective way to check if cancer has spread.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.